DOCEBO INC (DCBO) Fundamental Analysis & Valuation

NASDAQ:DCBO • CA25609L1058

Current stock price

16.2 USD
+0.56 (+3.58%)
At close:
16.71 USD
+0.51 (+3.15%)
Pre-Market:

This DCBO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. DCBO Profitability Analysis

1.1 Basic Checks

  • DCBO had positive earnings in the past year.
  • In the past year DCBO had a positive cash flow from operations.
  • Of the past 5 years DCBO 4 years were profitable.
  • Of the past 5 years DCBO 4 years had a positive operating cash flow.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

1.2 Ratios

  • DCBO's Return On Assets of 18.15% is amongst the best of the industry. DCBO outperforms 94.46% of its industry peers.
  • With an excellent Return On Equity value of 50.63%, DCBO belongs to the best of the industry, outperforming 95.94% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 28.07%, DCBO belongs to the best of the industry, outperforming 95.94% of the companies in the same industry.
  • DCBO had an Average Return On Invested Capital over the past 3 years of 16.11%. This is significantly above the industry average of 10.91%.
  • The last Return On Invested Capital (28.07%) for DCBO is above the 3 year average (16.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.15%
ROE 50.63%
ROIC 28.07%
ROA(3y)11.32%
ROA(5y)6.27%
ROE(3y)34.17%
ROE(5y)19.81%
ROIC(3y)16.11%
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200

1.3 Margins

  • Looking at the Profit Margin, with a value of 15.46%, DCBO belongs to the top of the industry, outperforming 82.29% of the companies in the same industry.
  • DCBO's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 12.13%, DCBO is in the better half of the industry, outperforming 78.60% of the companies in the same industry.
  • With an excellent Gross Margin value of 80.42%, DCBO belongs to the best of the industry, outperforming 81.55% of the companies in the same industry.
  • DCBO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.13%
PM (TTM) 15.46%
GM 80.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y46.55%
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y-0.34%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

7

2. DCBO Health Analysis

2.1 Basic Checks

  • DCBO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, DCBO has less shares outstanding
  • Compared to 5 years ago, DCBO has less shares outstanding
  • DCBO has a worse debt/assets ratio than last year.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • DCBO has an Altman-Z score of 2.45. This is not the best score and indicates that DCBO is in the grey zone with still only limited risk for bankruptcy at the moment.
  • DCBO's Altman-Z score of 2.45 is in line compared to the rest of the industry. DCBO outperforms 59.41% of its industry peers.
  • DCBO has a debt to FCF ratio of 0.09. This is a very positive value and a sign of high solvency as it would only need 0.09 years to pay back of all of its debts.
  • DCBO has a better Debt to FCF ratio (0.09) than 80.81% of its industry peers.
  • A Debt/Equity ratio of 0.03 indicates that DCBO is not too dependend on debt financing.
  • DCBO's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. DCBO outperforms 60.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Altman-Z 2.45
ROIC/WACC2.95
WACC9.51%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.22 indicates that DCBO should not have too much problems paying its short term obligations.
  • The Current ratio of DCBO (1.22) is worse than 64.94% of its industry peers.
  • A Quick Ratio of 1.22 indicates that DCBO should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.22, DCBO is doing worse than 64.58% of the companies in the same industry.
  • DCBO does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

9

3. DCBO Growth Analysis

3.1 Past

  • DCBO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.98%, which is quite impressive.
  • DCBO shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 88.99% yearly.
  • The Revenue has grown by 11.87% in the past year. This is quite good.
  • The Revenue has been growing by 30.99% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)56.98%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%18.42%
Revenue 1Y (TTM)11.87%
Revenue growth 3Y19.31%
Revenue growth 5Y30.99%
Sales Q2Q%10.51%

3.2 Future

  • DCBO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.29% yearly.
  • The Revenue is expected to grow by 26.95% on average over the next years. This is a very strong growth
EPS Next Y21%
EPS Next 2Y18.55%
EPS Next 3Y20.92%
EPS Next 5Y22.29%
Revenue Next Year10.97%
Revenue Next 2Y11.2%
Revenue Next 3Y11.56%
Revenue Next 5Y26.95%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

9

4. DCBO Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.00 indicates a reasonable valuation of DCBO.
  • Based on the Price/Earnings ratio, DCBO is valued cheaper than 85.61% of the companies in the same industry.
  • DCBO is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 9.92, the valuation of DCBO can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DCBO indicates a rather cheap valuation: DCBO is cheaper than 85.98% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 38.20. DCBO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12
Fwd PE 9.92
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • DCBO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DCBO is cheaper than 86.35% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, DCBO is valued cheaply inside the industry as 80.07% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.38
EV/EBITDA 10.63
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • DCBO has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as DCBO's earnings are expected to grow with 20.92% in the coming years.
PEG (NY)0.57
PEG (5Y)N/A
EPS Next 2Y18.55%
EPS Next 3Y20.92%

0

5. DCBO Dividend Analysis

5.1 Amount

  • No dividends for DCBO!.
Industry RankSector Rank
Dividend Yield 0%

DCBO Fundamentals: All Metrics, Ratios and Statistics

DOCEBO INC

NASDAQ:DCBO (4/15/2026, 8:00:02 PM)

Premarket: 16.71 +0.51 (+3.15%)

16.2

+0.56 (+3.58%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-27
Earnings (Next)05-08
Inst Owners36.6%
Inst Owner Change0%
Ins Owners0.46%
Ins Owner ChangeN/A
Market Cap418.28M
Revenue(TTM)242.69M
Net Income(TTM)37.51M
Analysts80
Price Target21.55 (33.02%)
Short Float %4%
Short Ratio1.72
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.78%
Min EPS beat(2)1.01%
Max EPS beat(2)22.55%
EPS beat(4)4
Avg EPS beat(4)19.42%
Min EPS beat(4)1.01%
Max EPS beat(4)28.07%
EPS beat(8)7
Avg EPS beat(8)27.59%
EPS beat(12)10
Avg EPS beat(12)11.91%
EPS beat(16)13
Avg EPS beat(16)101.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)-0.86%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.54%
Revenue beat(12)2
Avg Revenue beat(12)-0.68%
Revenue beat(16)2
Avg Revenue beat(16)-0.99%
PT rev (1m)-15.71%
PT rev (3m)-21.62%
EPS NQ rev (1m)-3.35%
EPS NQ rev (3m)2.08%
EPS NY rev (1m)1.76%
EPS NY rev (3m)7.17%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)3.06%
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)3.42%
Valuation
Industry RankSector Rank
PE 12
Fwd PE 9.92
P/S 1.72
P/FCF 15.38
P/OCF 14.85
P/B 5.65
P/tB 7.15
EV/EBITDA 10.63
EPS(TTM)1.35
EY8.33%
EPS(NY)1.63
Fwd EY10.08%
FCF(TTM)1.05
FCFY6.5%
OCF(TTM)1.09
OCFY6.74%
SpS9.4
BVpS2.87
TBVpS2.27
PEG (NY)0.57
PEG (5Y)N/A
Graham Number9.33604 (-42.37%)
Profitability
Industry RankSector Rank
ROA 18.15%
ROE 50.63%
ROCE 35.53%
ROIC 28.07%
ROICexc 263.9%
ROICexgc N/A
OM 12.13%
PM (TTM) 15.46%
GM 80.42%
FCFM 11.2%
ROA(3y)11.32%
ROA(5y)6.27%
ROE(3y)34.17%
ROE(5y)19.81%
ROIC(3y)16.11%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)20.39%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y46.55%
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y-0.34%
F-Score6
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Debt/EBITDA 0.06
Cap/Depr 30.79%
Cap/Sales 0.4%
Interest Coverage 250
Cash Conversion 86.37%
Profit Quality 72.49%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 2.45
F-Score6
WACC9.51%
ROIC/WACC2.95
Cap/Depr(3y)29.27%
Cap/Depr(5y)38.17%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.64%
Profit Quality(3y)239%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.98%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%18.42%
EPS Next Y21%
EPS Next 2Y18.55%
EPS Next 3Y20.92%
EPS Next 5Y22.29%
Revenue 1Y (TTM)11.87%
Revenue growth 3Y19.31%
Revenue growth 5Y30.99%
Sales Q2Q%10.51%
Revenue Next Year10.97%
Revenue Next 2Y11.2%
Revenue Next 3Y11.56%
Revenue Next 5Y26.95%
EBIT growth 1Y55.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.76%
EBIT Next 3Y44.38%
EBIT Next 5Y27.18%
FCF growth 1Y-2.9%
FCF growth 3Y182.43%
FCF growth 5Y48.94%
OCF growth 1Y-3.68%
OCF growth 3Y130.92%
OCF growth 5Y40.42%

DOCEBO INC / DCBO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DOCEBO INC?

ChartMill assigns a fundamental rating of 8 / 10 to DCBO.


What is the valuation status for DCBO stock?

ChartMill assigns a valuation rating of 9 / 10 to DOCEBO INC (DCBO). This can be considered as Undervalued.


What is the profitability of DCBO stock?

DOCEBO INC (DCBO) has a profitability rating of 8 / 10.


What is the financial health of DOCEBO INC (DCBO) stock?

The financial health rating of DOCEBO INC (DCBO) is 7 / 10.


What is the earnings growth outlook for DOCEBO INC?

The Earnings per Share (EPS) of DOCEBO INC (DCBO) is expected to grow by 21% in the next year.